Bausch Health Companies Inc. (BHC): Total Assets
$26.37B
As of 2025-12-31
$24.79B
As of 2026-06-30
+0.9%
3-year compound annual growth
-3.3%
5-year compound annual growth
-6.0%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $26.37B | -0.6% | 2026-02-19, Balance as of period end |
| 2024-12-31 | $26.52B | -3.0% | 2026-02-19, Balance as of period end |
| 2023-12-31 | $27.35B | +6.5% | 2025-02-20, Balance as of period end |
| 2022-12-31 | $25.69B | -12.0% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $29.20B | -6.4% | 2023-02-23, Balance as of period end |
| 2020-12-31 | $31.20B | -7.9% | 2022-02-23, Balance as of period end |
| 2019-12-31 | $33.86B | +4.2% | 2021-02-24, Balance as of period end |
| 2018-12-31 | $32.49B | -13.3% | 2020-02-19, Balance as of period end |
| 2017-12-31 | $37.50B | -13.9% | 2019-02-20, Balance as of period end |
| 2016-12-31 | $43.53B | -11.1% | 2018-02-28, Balance as of period end |
| 2015-12-31 | $48.97B | +86.1% | 2017-03-01, Balance as of period end |
| 2014-12-31 | $26.30B | -5.8% | 2016-04-29, Balance as of period end |
| 2013-12-31 | $27.93B | +55.6% | 2016-04-29, Balance as of period end |
| 2012-12-31 | $17.95B | +36.9% | 2015-02-25, Balance as of period end |
| 2011-12-31 | $13.11B | +21.4% | 2014-02-28, Balance as of period end |
| 2010-12-31 | $10.80B | +424.2% | 2013-02-28, Balance as of period end |
| 2009-12-31 | $2.06B | n/a | 2012-02-29, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $26.37B | -0.6% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $15.47B | +8.6% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $25.64B | +13.8% |
| Viatris Inc (VTRS) | 2025-12-31 | $37.19B | -10.4% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $40.56B | +7.4% |
| Organon & Co. (OGN) | 2025-12-31 | $12.87B | -1.8% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $40.75B | +3.6% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $8.19B | +38.3% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $13.36B | +5.9% |
Compare BHC, ZTS, VRTX, VTRS side by side · Screen every company in Pharmaceutical Preparations ↗